Breaking News Instant updates and real-time market news.

ARGX

Argenx

$137.83

2.78 (2.06%)

16:23
06/27/19
06/27
16:23
06/27/19
16:23

Argenx initiated with an Outperform at Baird

Baird analyst Michael Ulz initiated Argenx with a Buy and $170 price target telling investors it has a differentiated antibody platform and has built a robust pipeline. Ulz said efgartigimod has demonstrated a best-in-class profile with potential across multiple autoimmune diseases, and early data for cusatuzumab in AML looks promising. This combined with validating partnerships and multiple catalysts over the next two years support continued upside, the analyst wrote in a note to investors.

  • 09

    Sep

ARGX Argenx
$137.83

2.78 (2.06%)

05/23/19
PIPR
05/23/19
NO CHANGE
Target $182
PIPR
Overweight
Argenx price target raised to $182 from $161 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Argenx to $182 from $161 after the company debuted two first-in-class antibodies, ARGX-117 and ARGX-118. ARGX-117 is a C2 inhibitor with broad applicability in complement-mediated diseases including neuromuscular and kidney indications, while ARGX-117 is engineered with NHance technology to enable a "sweeping" mechanism that prevents lysosomal degradation and extends pharmacodynamic effect, Tenthoff tells investors in a research note. The analyst believes Argenx is competitively positioned from FcRn competitors with development of both intravenous and subcutaneous efgartigimod formulations. He reiterates an Overweight rating on the shares.
03/18/19
BTIG
03/18/19
INITIATION
BTIG
Neutral
Momenta initiated with a Neutral at BTIG
BTIG analyst Thomas Shrader initiated Momenta (MNTA) with a Neutral rating, saying that while he is positive on the company's IVIg-focused re-positioning, the stock is not cheap and the proof-of-concept for its analytical focus is at least a year away. The analyst also states that the bulk of his modeled value for the company comes from its pipeline development in treating maternal-fetal autoimmune disease, noting that competition in the space is "fierce" and that Momenta is "significantly behind Argenx (ARGX) in the development of FcRn blockers.
03/01/19
WEDB
03/01/19
NO CHANGE
Target $131
WEDB
Outperform
Argenx removed from Best Ideas List at Wedbush
Wedbush removed Argenx from the Best Ideas List on valuation as the stock is up about 66% vs. the S&P 500 since it was added to the list in September. The firm remains positive on the name and sees several value-adding events in 2019, but does not see any major share catalysts for the year.
02/22/19
GUGG
02/22/19
INITIATION
Target $157
GUGG
Buy
Argenx initiated with a Buy at Guggenheim
Guggenheim analyst Yatin Suneja initiated Argenx with a Buy rating and $157 price target, citing his view that efgartigimod, the company's lead asset, offers a best and first-in-class profile with applicability across several autoimmune diseases.

TODAY'S FREE FLY STORIES

ACAD

Acadia

$25.97

0.28 (1.09%)

08:09
07/23/19
07/23
08:09
07/23/19
08:09
Recommendations
Acadia analyst commentary  »

Acadia schizophrenia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 20

    Aug

CACI

CACI

$210.64

(0.00%)

08:09
07/23/19
07/23
08:09
07/23/19
08:09
Hot Stocks
CACI awarded $232M contract by Intelligence Community customer »

CACI announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

AAPL

Apple

$207.21

4.59 (2.27%)

, INTC

Intel

$51.36

1.1 (2.19%)

08:09
07/23/19
07/23
08:09
07/23/19
08:09
Recommendations
Apple, Intel, Qualcomm analyst commentary  »

Apple potential…

AAPL

Apple

$207.21

4.59 (2.27%)

INTC

Intel

$51.36

1.1 (2.19%)

QCOM

Qualcomm

$75.93

0.9 (1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 30

    Jul

  • 31

    Jul

  • 03

    Aug

ORIT

Oritani Financial

$17.41

0.02 (0.12%)

, VLY

Valley National

$10.67

-0.02 (-0.19%)

08:08
07/23/19
07/23
08:08
07/23/19
08:08
Earnings
Oritani Financial reports Q4 EPS 30c, consensus 27c »

"As we look forward…

ORIT

Oritani Financial

$17.41

0.02 (0.12%)

VLY

Valley National

$10.67

-0.02 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 14

    Aug

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

08:08
07/23/19
07/23
08:08
07/23/19
08:08
Hot Stocks
Lockheed Martin boosts FY19 segment operating profit view to $6.325B-$6.475B »

Previous view was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ATNM

Actinium Pharmaceuticals

$0.23

-0.0051 (-2.13%)

08:06
07/23/19
07/23
08:06
07/23/19
08:06
Hot Stocks
Actinium Pharma achieves 50% patient enrollment for Phase 3 Sierra trial »

Actinium Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTD

Mettler-Toledo

$818.56

3.57 (0.44%)

08:06
07/23/19
07/23
08:06
07/23/19
08:06
Downgrade
Mettler-Toledo rating change  »

Mettler-Toledo downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

ANFI

Amira Nature Foods

$0.70

(0.00%)

08:06
07/23/19
07/23
08:06
07/23/19
08:06
Hot Stocks
Amira Nature Foods expects to sell over $12M of edible oils in FY20 »

Amira Nature Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SOLY

Soliton

$14.75

2.62 (21.60%)

08:05
07/23/19
07/23
08:05
07/23/19
08:05
Hot Stocks
Soliton granted key patent by European Patent Office »

Soliton announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FELE

Franklin Electric

$45.70

0.11 (0.24%)

08:05
07/23/19
07/23
08:05
07/23/19
08:05
Earnings
Franklin Electric lowers FY19 EPS ex-restructuring charges view $2.15-$2.25 »

Previous view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

VIVE

Viveve

$0.41

-0.0155 (-3.68%)

08:04
07/23/19
07/23
08:04
07/23/19
08:04
Downgrade
Viveve rating change  »

Viveve downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQIX

Equinix

$506.49

-0.11 (-0.02%)

, AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

08:04
07/23/19
07/23
08:04
07/23/19
08:04
Hot Stocks
Equinix strengthens relationship with Amazon Web Services »

Equinix (EQIX) announced…

EQIX

Equinix

$506.49

-0.11 (-0.02%)

AMZN

Amazon.com

$1,985.93

21.15 (1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 31

    Jul

  • 16

    Sep

  • 17

    Sep

PCAR

Paccar

$69.17

-0.16 (-0.23%)

08:04
07/23/19
07/23
08:04
07/23/19
08:04
Earnings
Paccar reports Q2 EPS $1.78, consensus $1.81 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LMT

Lockheed Martin

$357.57

0.675 (0.19%)

08:03
07/23/19
07/23
08:03
07/23/19
08:03
Hot Stocks
Breaking Hot Stocks news story on Lockheed Martin »

Lockheed Martin up 2.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

G

Genpact

$38.68

0.16 (0.42%)

08:03
07/23/19
07/23
08:03
07/23/19
08:03
Hot Stocks
Genpact extends relationship with IRI »

Genpact announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

FELE

Franklin Electric

$45.70

0.11 (0.24%)

08:02
07/23/19
07/23
08:02
07/23/19
08:02
Earnings
Franklin Electric reports Q2 EPS ex-items 70c, consensus 72c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

LPCN

Lipocine

$1.82

-0.025 (-1.36%)

08:01
07/23/19
07/23
08:01
07/23/19
08:01
Hot Stocks
Lipocine to join Rusell Microcap Index »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRTX

Karuna Therapeutics

$19.79

0.01 (0.05%)

08:01
07/23/19
07/23
08:01
07/23/19
08:01
Initiation
Karuna Therapeutics initiated  »

Karuna Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$15.38

0.31 (2.06%)

08:00
07/23/19
07/23
08:00
07/23/19
08:00
Options
US Steel call buyer realizes 108% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

MRNS

Marinus Pharmaceuticals

$3.99

0.11 (2.84%)

08:00
07/23/19
07/23
08:00
07/23/19
08:00
Hot Stocks
Breaking Hot Stocks news story on Marinus Pharmaceuticals »

Marinus Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREE

LendingTree

$414.78

4.35 (1.06%)

07:57
07/23/19
07/23
07:57
07/23/19
07:57
Recommendations
LendingTree analyst commentary  »

LendingTree price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 13

    Nov

CTL

CenturyLink

$11.08

-0.29 (-2.55%)

, GLW

Corning

$33.35

0.24 (0.72%)

07:56
07/23/19
07/23
07:56
07/23/19
07:56
Hot Stocks
CenturyLink expands fiber network in U.S. and Europe »

CenturyLink (CTL) is…

CTL

CenturyLink

$11.08

-0.29 (-2.55%)

GLW

Corning

$33.35

0.24 (0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 07

    Aug

BCS

Barclays

$7.81

0.04 (0.51%)

, APO

Apollo Global

$35.09

0.79 (2.30%)

07:55
07/23/19
07/23
07:55
07/23/19
07:55
Periodicals
Disgraced Epstein had close ties to top Wall Street executives, NY Times reports »

Jeffrey Epstein, the…

BCS

Barclays

$7.81

0.04 (0.51%)

APO

Apollo Global

$35.09

0.79 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 01

    Aug

07:55
07/23/19
07/23
07:55
07/23/19
07:55
General news
U.S. chain store sales dropped another 0.6% in the week ended July 20 »

U.S. chain store sales…

COT

Cott Corp.

$12.29

0.005 (0.04%)

07:53
07/23/19
07/23
07:53
07/23/19
07:53
Recommendations
Cott Corp. analyst commentary  »

Cott Corp. pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.